SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
Access to genomic testing, not therapy cost, is the biggest challenge
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
The public health summit in Addis Ababa will bring together policymakers, scientists, healthcare leaders, and global partners
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
